These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20040773)

  • 21. Five-year follow-up of substantia nigra echogenicity in idiopathic REM sleep behavior disorder.
    Iranzo A; Stockner H; Serradell M; Seppi K; Valldeoriola F; Frauscher B; Molinuevo JL; Vilaseca I; Mitterling T; Gaig C; Vilas D; Santamaria J; Högl B; Tolosa E; Poewe W
    Mov Disord; 2014 Dec; 29(14):1774-80. PubMed ID: 25384461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feature analysis for Parkinson's disease detection based on transcranial sonography image.
    Chen L; Hagenah J; Mertins A
    Med Image Comput Comput Assist Interv; 2012; 15(Pt 3):272-9. PubMed ID: 23286140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
    Zecca L; Berg D; Arzberger T; Ruprecht P; Rausch WD; Musicco M; Tampellini D; Riederer P; Gerlach M; Becker G
    Mov Disord; 2005 Oct; 20(10):1278-85. PubMed ID: 15986424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcranial imaging of substantia nigra hyperechogenicity in a Taiwanese cohort of Parkinson's disease.
    Huang YW; Jeng JS; Tsai CF; Chen LL; Wu RM
    Mov Disord; 2007 Mar; 22(4):550-5. PubMed ID: 17260344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Substantia nigra echogenicity: A structural correlate of functional impairment of the dopaminergic striatal projection in Parkinson's disease.
    Weise D; Lorenz R; Schliesser M; Schirbel A; Reiners K; Classen J
    Mov Disord; 2009 Aug; 24(11):1669-75. PubMed ID: 19514075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substantia nigra echogenicity and imaging of striatal dopamine transporters in Parkinson's disease: a cross-sectional study.
    Bor-Seng-Shu E; Pedroso JL; Felicio AC; de Andrade DC; Teixeira MJ; Braga-Neto P; Batista IR; Barsottini OG; Borges V; Ferraz HB; Shih MC; Bressan RA; de Andrade LA; Walter U
    Parkinsonism Relat Disord; 2014 May; 20(5):477-81. PubMed ID: 24629800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcranial brain sonography findings in discriminating between parkinsonism and idiopathic Parkinson disease.
    Walter U; Dressler D; Probst T; Wolters A; Abu-Mugheisib M; Wittstock M; Benecke R
    Arch Neurol; 2007 Nov; 64(11):1635-40. PubMed ID: 17998447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transcranial sonography of the substantia nigra: digital image analysis.
    Skoloudík D; Jelínková M; Blahuta J; Cermák P; Soukup T; Bártová P; Langová K; Herzig R
    AJNR Am J Neuroradiol; 2014 Dec; 35(12):2273-8. PubMed ID: 25059698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Echogenicity of the substantia nigra in relatives of patients with sporadic Parkinson's disease.
    Ruprecht-Dörfler P; Berg D; Tucha O; Benz P; Meier-Meitinger M; Alders GL; Lange KW; Becker G
    Neuroimage; 2003 Feb; 18(2):416-22. PubMed ID: 12595195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study.
    Yu SY; Cao CJ; Zuo LJ; Chen ZJ; Lian TH; Wang F; Hu Y; Piao YS; Li LX; Guo P; Liu L; Yu QJ; Wang RD; Chan P; Chen SD; Wang XM; Zhang W
    BMC Neurol; 2018 Jan; 18(1):9. PubMed ID: 29343241
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of substantia nigra echogenicities in 3D transcranial ultrasound for early diagnosis of Parkinson disease.
    Pauly O; Ahmadi SA; Plate A; Boetzel K; Navab N
    Med Image Comput Comput Assist Interv; 2012; 15(Pt 3):443-50. PubMed ID: 23286161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcranial brain sonography in Parkinson's disease with restless legs syndrome.
    Kwon DY; Seo WK; Yoon HK; Park MH; Koh SB; Park KW
    Mov Disord; 2010 Jul; 25(10):1373-8. PubMed ID: 20544813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Echogenicity of the substantia nigra region in Parkinson's disease.
    Bor-Seng-Shu E; Almeida KJ; Andrade DC; Fonoff ET; Teixeira MJ; Barbosa ER
    Arq Neuropsiquiatr; 2012 Feb; 70(2):153-4. PubMed ID: 22311223
    [No Abstract]   [Full Text] [Related]  

  • 34. Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders.
    Walter U; Hoeppner J; Prudente-Morrissey L; Horowski S; Herpertz SC; Benecke R
    Brain; 2007 Jul; 130(Pt 7):1799-807. PubMed ID: 17329323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reproducibility of sonographic measurement of the substantia nigra.
    Skoloudík D; Fadrná T; Bártová P; Langová K; Ressner P; Zapletalová O; Hlustík P; Herzig R; Kannovský P
    Ultrasound Med Biol; 2007 Sep; 33(9):1347-52. PubMed ID: 17544567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and imaging markers in premotor LRRK2 G2019S mutation carriers.
    Vilas D; Ispierto L; Álvarez R; Pont-Sunyer C; Martí MJ; Valldeoriola F; Compta Y; de Fabregues O; Hernández-Vara J; Puente V; Calopa M; Jaumà S; Campdelacreu J; Aguilar M; Quílez P; Casquero P; Lomeña F; Ríos J; Tolosa E
    Parkinsonism Relat Disord; 2015 Oct; 21(10):1170-6. PubMed ID: 26306001
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.
    Walter U; Wittstock M; Benecke R; Dressler D
    J Neural Transm (Vienna); 2002 Feb; 109(2):191-6. PubMed ID: 12075859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does normal substantia nigra echogenicity make a difference in Parkinson's disease diagnosis? A real clinical practice follow-up study.
    Alonso-Canovas A; Lopez-Sendon Moreno JL; Buisan J; Sainz de la Maza S; Costa-Frossard L; Garcia-Ribas G; de Felipe-Mimbrera A; Matute-Lozano MC; Zarza Sanz B; Toledano Delgado R; Corral I; Masjuan J; Martinez-Castrillo JC
    J Neurol; 2018 Oct; 265(10):2363-2369. PubMed ID: 30116942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Transcranial Sonography Evaluation of Substantia Nigra Hyperechogenicity Is Useful for Predicting Levodopa-Induced Dyskinesia in Parkinson Disease.
    Yan JH; Li K; Ge YL; Li W; Wang PZ; Jin H; Zhang JR; Chen J; Wang F; Yang YP; Zhang YC; Li D; Mao CJ; Liu CF
    Ultrasound Med Biol; 2023 Feb; 49(2):607-615. PubMed ID: 36456377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcranial sonography of the substantia nigra and MIBG myocardial scintigraphy: complementary role in the diagnosis of Parkinson's disease.
    Kajimoto Y; Miwa H; Okawa-Izawa M; Hironishi M; Kondo T
    Parkinsonism Relat Disord; 2009 May; 15(4):270-2. PubMed ID: 18691928
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.